Clinical Trial Update: An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma [Phase 2]

View source ↗

Summary

Phase 2 efficacy study of oral Milataxel (TL139) for malignant mesothelioma. The document provides trial information but does not report results in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• Milataxel (TL139)

Snippet

Sponsor: Taxolog Inc. | Conditions: Mesothelioma | Phase 2 | Status: UNKNOWN